Viewing Study NCT00000866


Ignite Creation Date: 2025-12-24 @ 4:08 PM
Ignite Modification Date: 2026-01-05 @ 3:08 AM
Study NCT ID: NCT00000866
Status: COMPLETED
Last Update Posted: 2021-10-28
First Post: 1999-11-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module